Inhibrx Biosciences Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Inhibrx Biosciences stock have an average target of 277.5, with a low estimate of 230 and a high estimate of 325. The average target predicts an increase of 192.69% from the current stock price of 94.81.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$230	$277.5	$325	$325
Change	+142.59%	+192.69%	+242.79%	+242.79%

Analyst Ratings

The average analyst rating for Inhibrx Biosciences stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	0	0	0	1	2	2
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	2	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dara Azar Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $325	Buy	Maintains	$325	+242.79%	Jun 2, 2026
Oliver McCammon LifeSci Capital	LifeSci Capital	Buy Maintains $230	Buy	Maintains	$230	+142.59%	May 16, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 1.30M

-100.00%

from 1.30M

Revenue Next Year

57.18M

EPS This Year

-9.26

from -9.04

EPS Next Year

-6.30

from -9.26

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	7.23M	1.32M	1.80M	200.00K	1.30M	-	57.18M
Revenue Growth	-43.89%	-81.81%	36.88%	-88.89%	550.00%	-100.00%	-
EPS	-2.15	-2.88	-20.48	112.62	-9.04	-9.71	-6.99
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	60.3M
Avg	n/a	57.2M
Low	n/a	54.1M

Revenue Growth

Revenue Growth	2026	2027
High	-100.0%	-
Avg	-100.0%	-
Low	-100.0%	-

EPS Forecast

EPS	2026	2027
High	-9.26	-6.30
Avg	-9.26	-6.30
Low	-9.26	-6.30

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.